Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Pharma ADMET Testing Global Market Report 2025
Download Free Sample Buy Now
Global Pharma ADMET Testing Market Report 2025

Report Price : $4490.00

Pages :

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Pharma ADMET Testing Global Market Report 2025

By Testing Type (In Vivo ADMET Testing, In Vitro ADMET Testing, In Silico ADMET Testing), By Technology (Cell Culture, High Throughput, Molecular Imaging, OMICS Technology), By Application (Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, Other Applications) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Pharma ADMET Testing Market Overview

• Pharma ADMET Testing market size has reached to $9.67 billion in 2024

• Expected to grow to $17.03 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%

• Growth Driver: The Influence Of Increasing Product Approvals On The Pharma ADMET Testing Market

• Market Trend: The Impact Of Product Innovations On The Pharma ADMET Testing Market

• Asia-Pacific was the largest region in 2024.

What Is Covered Under Pharma ADMET Testing Market?

Pharma ADMET testing refers to a set of procedures and assays used in the pharmaceutical industry to assess the Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) of drug candidates. It is used for determining the safety and efficacy of potential drugs before they can be approved for clinical use.

The main types of pharma ADMET testing are in vivo ADMET testing, in vitro ADMET testing, and in silico ADMET testing. In vivo ADMET testing refers to the assessment of a drug's absorption, distribution, metabolism, excretion, and toxicity properties within a living organism. Pharma ADMET testing is used in drug discovery and development processes to identify potential drug candidates with desirable pharmacokinetic properties. The technologies include cell culture, high throughput, molecular imaging, and OMICS technology which are used in systemic toxicity, renal toxicity, hepatotoxicity, neurotoxicity, and others.

Pharma ADMET Testing Market Size and growth rate 2025 to 2029: Graph

What Is The Pharma ADMET Testing Market Size 2025 And Growth Rate?

The pharma ADMET testing market size has grown rapidly in recent years. It will grow from $9.67 billion in 2024 to $10.7 billion in 2025 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to growth in biopharmaceuticals and biosimilars, rise in drug development activities, growing awareness of drug safety, globalization of clinical trials, shift towards in silico modeling

What Is The Pharma ADMET Testing Market Growth Forecast?

The pharma ADMET testing market size is expected to see rapid growth in the next few years. It will grow to $17.03 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to environmental toxicology and safety assessment, awareness of pharmacogenomics, focus on precision medicine, growth of biologics and biosimilars, integration of artificial intelligence (AI), expanded regulatory requirements, rise in orphan drug development. Major trends in the forecast period include increasing collaboration in research, rapid technological innovations, advancements in analytical technologies, continuous monitoring of drug safety, and environmental impact considerations.

The forecast of 12.3% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. drug developers by driving up the cost of high-throughput ADMET screening systems and 3D liver microtissues sourced from Belgium and Japan, exacerbating R&D expenses and delaying new drug approvals. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Pharma ADMET Testing Market Segmented?

1) By Testing Type: In Vivo ADMET Testing, In Vitro ADMET Testing, In Silico ADMET Testing

2) By Technology: Cell Culture, High Throughput, Molecular Imaging, OMICS Technology

3) By Application: Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, Other Applications

Subsegments:

1) By In Vivo ADMET Testing: Animal Studies, Pharmacokinetics Studies, Toxicology Studies, Biodistribution Studies

2) By In Vitro ADMET Testing: Metabolism Studies, Drug-Drug Interaction Studies, Absorption Studies, Cytotoxicity and Safety Testing

3) By In Silico ADMET Testing: Predictive Modeling and Simulation, Quantitative Structure-Activity Relationship (QSAR) Analysis, Machine Learning Algorithms for ADMET Predictions, Software Tools for ADMET Profiling

What Is Driving The Pharma ADMET Testing Market? The Influence Of Increasing Product Approvals On The Pharma ADMET Testing Market

The rising number of product approvals is driving the pharma ADMET testing market. Product approvals refer to the process by which regulatory authorities, such as the Food and Drug Administration (FDA) in the United States or the European Medicines Agency (EMA) in Europe, grant permission for a product to be marketed and sold to the public. ADMET testing is beneficial for determining the safety and efficacy of novel products and is mandatory in product regulatory approvals. For instance, in January 2024, according to the National Library of Medicine, a US-based biomedical library and a national resource for health professionals, there were 55 new drugs approved by the U.S. Food and Drug Administration (FDA) in 2023, up from 37 drugs approved in 2022. Therefore, the rising number of product approvals drives the pharma ADMET testing industry.

What Is Driving The Pharma ADMET Testing Market? The Impact Of Escalating Clinical Trials On The Pharma ADMET Testing Market

The increase in the number of clinical trials is expected to boost the growth of the pharma ADMET testing market going forward. A clinical trial is a research study conducted with human participants to evaluate the safety, efficacy, and potential side effects of a medical intervention, such as a new drug, medical device, diagnostic procedure, or treatment regimen. The upswing in clinical trials markedly elevates the demand for thorough assessments of drug safety and efficacy within the pharma ADMET testing market, emphasizing the critical need for tailored evaluations across diverse drug candidates and patient populations. For instance, in May 2023, according to a report published by Xtalks, a Canada-based web news and information network, 452,604 clinical studies have been registered on ClinicalTrials.gov as of May 2023. This marks a significant rise from the more than 365,000 registered trials that were recorded in early 2021. Therefore, the increase in the number of clinical trials is driving the growth of the pharma ADMET testing industry.

Who Are The Major Players In The Global Pharma ADMET Testing Market?

Major companies operating in the pharma ADMET testing market include Thermo Fisher Scientific Inc., The Merck Group, Laboratory Corporation of America Holdings, IQVIA Inc., PPD ICON plc, Agilent Technologies Inc., Wuxi AppTec Co. Ltd., Catalent Inc., Covance Inc., Charles River Laboratories International Inc., Eurofins Scientific SE, Beckman Coulter Inc., Perkinelmer Inc., Albany Molecular Research Inc., Evotec A.G., CMIC Holdings Co. Ltd., Promega Corporation, Aptuit LLC, Symeres B.V., Biovia Corp., BioIVT LLC, Cyprotex Limited, InSphero AG, Admescope Ltd., Accelrys Inc.

What Are The Key Trends Of The Global Pharma ADMET Testing Market? The Impact Of Product Innovations On The Pharma ADMET Testing Market

Product innovations are a key trend gaining popularity in the pharma ADMET testing market. Major companies in the pharma ADMET testing market are introducing innovative products such as Logica to sustain their position in the market. For instance, in April 2022, Charles River Laboratories International Inc., a US-based pharmaceutical company, and Valo Health Inc., a US-based AI-health solution company, launched Logica, an AI-based drug development solution. The new solution leverages Valo's AI-powered Opal Computational Platform to provide users with ADMET testing services and other drug delivery solutions. Logica makes use of industry-leading predictive models, chemical design and synthesis capabilities, DNA encoded libraries, and in silico high throughput screening from Valo's Opal Computational Platform, in addition to the Charles River’s leading capabilities in all aspects of discovery optimization including high throughput screening, medicinal chemistry, ADME, biology, pharmacology, and ultimately safety testing and IND submission.

What Are The Key Trends Of The Global Pharma ADMET Testing Market? Strategic Partnerships Drive Progress In The Pharma ADMET Testing Market

Major companies operating in the pharma ADMET testing market are adopting a strategic partnership approach to improve efforts in discovering allosteric drugs. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. For instance, in May 2022, Excelra, a US-based company that accelerates drug discovery and development leveraging advanced data science, partnered with HotSpot Therapeutics Inc., a US-based biotechnology company that develops small molecule allosteric therapies. The partnership aims to boost HotSpot's drug discovery and development initiatives by integrating Excelra's premier product, GOSTAR, and its meticulously annotated datasets into HotSpot's machine learning (ML) and artificial intelligence (AI) models. Through the incorporation of GOSTAR data, HotSpot seeks to propel the exploration and creation of small molecule therapeutic candidates targeted at allosteric sites that have traditionally posed challenges for drug development using conventional approaches. GOSTAR offers a comprehensive perspective on over 8 million small molecules, providing the latest insights into the chemical space, encompassing details on chemical structures and diverse biological properties, including binding, in vitro, in vivo, ADME, toxicology, and physicochemical properties.

Need data on a specific region in this market?
Request Regional Data

Pharma ADMET Testing Market Merger And Acquisition: BioIVT Acquired Xenotech

In September 2022, BioIVT, a US-based drug development solutions provider, acquired XenoTech for an undisclosed amount. The acquisition complements the product portfolio of BioIVT and helps it expand its product offerings in newer geographies and to a broader customer base. XenoTech is a US-based contract research organization providing ADMET testing services.

Regional Outlook For The Global Pharma ADMET Testing Market

Asia-Pacific was the largest region in the pharma ADMET testing market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Pharma ADMET Testing Market?

The pharma ADMET testing market consists of revenues earned by entities by providing services such as in vitro screening, in vitro metabolism, and metabolite testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The pharma ADMET testing market also includes the sales of membranes, buffer systems, and analytes that are used in the assays. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Pharma ADMET Testing Industry?

The pharma admet testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pharma admet testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Pharma ADMET Testing Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $10.7 billion
Revenue Forecast In 2034 $17.03 billion
Growth Rate CAGR of 12.3% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Testing Type: In Vivo ADMET Testing, In Vitro ADMET Testing, In Silico ADMET Testing
2) By Technology: Cell Culture, High Throughput, Molecular Imaging, OMICS Technology
3) By Application: Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, Other Applications Subsegments: 1) By In Vivo ADMET Testing: Animal Studies, Pharmacokinetics Studies, Toxicology Studies, Biodistribution Studies
2) By In Vitro ADMET Testing: Metabolism Studies, Drug-Drug Interaction Studies, Absorption Studies, Cytotoxicity and Safety Testing
3) By In Silico ADMET Testing: Predictive Modeling and Simulation, Quantitative Structure-Activity Relationship (QSAR) Analysis, Machine Learning Algorithms for ADMET Predictions, Software Tools for ADMET Profiling
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Thermo Fisher Scientific Inc., The Merck Group, Laboratory Corporation of America Holdings, IQVIA Inc., PPD ICON plc, Agilent Technologies Inc., Wuxi AppTec Co. Ltd., Catalent Inc., Covance Inc., Charles River Laboratories International Inc., Eurofins Scientific SE, Beckman Coulter Inc., Perkinelmer Inc., Albany Molecular Research Inc., Evotec A.G., CMIC Holdings Co. Ltd., Promega Corporation, Aptuit LLC, Symeres B.V., Biovia Corp., BioIVT LLC, Cyprotex Limited, InSphero AG, Admescope Ltd., Accelrys Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Pharma ADMET Testing Market Characteristics

3. Pharma ADMET Testing Market Trends And Strategies

4. Pharma ADMET Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Pharma ADMET Testing Growth Analysis And Strategic Analysis Framework

5.1. Global Pharma ADMET Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Pharma ADMET Testing Market Growth Rate Analysis

5.4. Global Pharma ADMET Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Pharma ADMET Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Pharma ADMET Testing Total Addressable Market (TAM)

6. Pharma ADMET Testing Market Segmentation

6.1. Global Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

In Vivo ADMET Testing

In Vitro ADMET Testing

In Silico ADMET Testing

6.2. Global Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cell Culture

High Throughpu

Molecular Imaging

OMICS Technology

6.3. Global Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Systemic Toxicity

Renal Toxicity

Hepatotoxicity

Neurotoxicity

Other Applications

6.4. Global Pharma ADMET Testing Market, Sub-Segmentation Of In Vivo ADMET Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Animal Studies

Pharmacokinetics Studies

Toxicology Studies

Biodistribution Studies

6.5. Global Pharma ADMET Testing Market, Sub-Segmentation Of In Vitro ADMET Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Metabolism Studies

Drug-Drug Interaction Studies

Absorption Studies

Cytotoxicity and Safety Testing

6.6. Global Pharma ADMET Testing Market, Sub-Segmentation Of In Silico ADMET Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Predictive Modeling and Simulation

Quantitative Structure-Activity Relationship (QSAR) Analysis

Machine Learning Algorithms for ADMET Predictions

Software Tools for ADMET Profiling

7. Pharma ADMET Testing Market Regional And Country Analysis

7.1. Global Pharma ADMET Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Pharma ADMET Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pharma ADMET Testing Market

8.1. Asia-Pacific Pharma ADMET Testing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pharma ADMET Testing Market

9.1. China Pharma ADMET Testing Market Overview

9.2. China Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pharma ADMET Testing Market

10.1. India Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pharma ADMET Testing Market

11.1. Japan Pharma ADMET Testing Market Overview

11.2. Japan Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pharma ADMET Testing Market

12.1. Australia Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pharma ADMET Testing Market

13.1. Indonesia Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pharma ADMET Testing Market

14.1. South Korea Pharma ADMET Testing Market Overview

14.2. South Korea Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pharma ADMET Testing Market

15.1. Western Europe Pharma ADMET Testing Market Overview

15.2. Western Europe Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pharma ADMET Testing Market

16.1. UK Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pharma ADMET Testing Market

17.1. Germany Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pharma ADMET Testing Market

18.1. France Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pharma ADMET Testing Market

19.1. Italy Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pharma ADMET Testing Market

20.1. Spain Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pharma ADMET Testing Market

21.1. Eastern Europe Pharma ADMET Testing Market Overview

21.2. Eastern Europe Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pharma ADMET Testing Market

22.1. Russia Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pharma ADMET Testing Market

23.1. North America Pharma ADMET Testing Market Overview

23.2. North America Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pharma ADMET Testing Market

24.1. USA Pharma ADMET Testing Market Overview

24.2. USA Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pharma ADMET Testing Market

25.1. Canada Pharma ADMET Testing Market Overview

25.2. Canada Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pharma ADMET Testing Market

26.1. South America Pharma ADMET Testing Market Overview

26.2. South America Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pharma ADMET Testing Market

27.1. Brazil Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pharma ADMET Testing Market

28.1. Middle East Pharma ADMET Testing Market Overview

28.2. Middle East Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pharma ADMET Testing Market

29.1. Africa Pharma ADMET Testing Market Overview

29.2. Africa Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pharma ADMET Testing Market Competitive Landscape And Company Profiles

30.1. Pharma ADMET Testing Market Competitive Landscape

30.2. Pharma ADMET Testing Market Company Profiles

30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. The Merck Group Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis

30.2.4. IQVIA Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. PPD ICON plc Overview, Products and Services, Strategy and Financial Analysis

31. Pharma ADMET Testing Market Other Major And Innovative Companies

31.1. Agilent Technologies Inc.

31.2. Wuxi AppTec Co. Ltd.

31.3. Catalent Inc.

31.4. Covance Inc.

31.5. Charles River Laboratories International Inc.

31.6. Eurofins Scientific SE

31.7. Beckman Coulter Inc.

31.8. Perkinelmer Inc.

31.9. Albany Molecular Research Inc.

31.10. Evotec A.G.

31.11. CMIC Holdings Co. Ltd.

31.12. Promega Corporation

31.13. Aptuit LLC

31.14. Symeres B.V.

31.15. Biovia Corp.

32. Global Pharma ADMET Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharma ADMET Testing Market

34. Recent Developments In The Pharma ADMET Testing Market

35. Pharma ADMET Testing Market High Potential Countries, Segments and Strategies

35.1 Pharma ADMET Testing Market In 2029 - Countries Offering Most New Opportunities

35.2 Pharma ADMET Testing Market In 2029 - Segments Offering Most New Opportunities

35.3 Pharma ADMET Testing Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Pharma ADMET Testing Market, Sub-Segmentation Of In Vivo ADMET Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Pharma ADMET Testing Market, Sub-Segmentation Of In Vitro ADMET Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Pharma ADMET Testing Market, Sub-Segmentation Of In Silico ADMET Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Pharma ADMET Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Pharma ADMET Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Thermo Fisher Scientific Inc. Financial Performance
  • Table 78: The Merck Group Financial Performance
  • Table 79: Laboratory Corporation of America Holdings Financial Performance
  • Table 80: IQVIA Inc. Financial Performance
  • Table 81: PPD ICON plc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Pharma ADMET Testing Market, Sub-Segmentation Of In Vivo ADMET Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Pharma ADMET Testing Market, Sub-Segmentation Of In Vitro ADMET Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Pharma ADMET Testing Market, Sub-Segmentation Of In Silico ADMET Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Pharma ADMET Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Pharma ADMET Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 78: The Merck Group Financial Performance
  • Figure 79: Laboratory Corporation of America Holdings Financial Performance
  • Figure 80: IQVIA Inc. Financial Performance
  • Figure 81: PPD ICON plc Financial Performance

Next-Gen Primary Health Care Service : Market Forecast, Transformation, and Long-Term Trajectories

Read More About Next-Gen Primary Health Care Service : Market Forecast, Transformation, and Long-Term Trajectories

Progressive Ataxia And Weakness Disorders Growth Trajectory: Key Forecasts and Strategic Insights

Read More About Progressive Ataxia And Weakness Disorders Growth Trajectory: Key Forecasts and Strategic Insights

Prostate Cancer Nuclear Medicine Diagnostics Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Read More About Prostate Cancer Nuclear Medicine Diagnostics Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Emerging Trends Redefining the Prostate Cancer Nuclear Medicine Diagnostics Market Landscape: Automated Parallel Capillary Electrophoresis Systems Transforming Protein Analysis In The Protein Chip Market

Read More About Emerging Trends Redefining the Prostate Cancer Nuclear Medicine Diagnostics Market Landscape: Automated Parallel Capillary Electrophoresis Systems Transforming Protein Analysis In The Protein Chip Market

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Read More About Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Read More About Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Pharma ADMET Testing Global Market Report 2025 – By Testing Type (In Vivo ADMET Testing, In Vitro ADMET Testing, In Silico ADMET Testing), By Technology (Cell Culture, High Throughput, Molecular Imaging, OMICS Technology...

View Report

ADME Toxicology Testing Global Market Report 2025 – By Product Type (Instruments, Software Solutions, Assays Systems, Reagents, Other Products), By Method (Cellular Assay, Biochemical Assay, In Silica, Ex-vivo), By Techn...

View Report

Testing Software Global Market Report 2025 – By Type (System Integrator, Pureplay Testing Software), By Component (Application Testing, Services), By End-User (BFSI (Banking, Financial Service and Insurance), IT (Informa...

View Report

Software Testing Global Market Report 2025 – By Type (System Integrator, Pureplay Software Testing), By Component (Application Testing, Services), By Application (IT and Telecom, BFSI, Manufacturing, Retail, Healthcare, ...

View Report

Pharmaceutical Packaging Testing Equipment Global Market Report 2025 – By Type (Services, Equipment), By Product (Primary Packaging Equipment, Secondary Packaging Equipment, Labeling And Serialization Equipment), By End ...

View Report

Biologics Testing Global Market Report 2025 – By Product (Reagents And Kits, Instruments, Other Products), By Test Type (Endotoxin Test, Sterility Test, Mycoplasma Tests, Bioburden Tests, Residual Host-Cell Proteins And ...

View Report

Drugs of Abuse (DOA) Testing Global Market Report 2025 – By Product And Service (Analyzers, Rapid Testing Devices, Consumables, Laboratory Services), By Sample Type (Urine, Hair, Oral Fluid, Breath), By Application (Pain...

View Report

Dietary Supplement Testing Services Global Market Report 2025 – By Service (Stability Testing, Analytical Testing, Microbiological Testing, Regulatory Testing And Compliance, Other Services), By Ingredient (Herbal, Vitam...

View Report

Frequently Asked Questions

Pharma ADMET testing refers to a set of procedures and assays used in the pharmaceutical industry to assess the Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) of drug candidates. It is used for determining the safety and efficacy of potential drugs before they can be approved for clinical use. For further insights on this market, request a sample here

The market major growth driver - The Influence Of Increasing Product Approvals On The Pharma ADMET Testing Market. For further insights on this market, request a sample here

The pharma admet testing market size has grown rapidly in recent years. It will grow from $9.67 billion in 2024 to $10.7 billion in 2025 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to growth in biopharmaceuticals and biosimilars, rise in drug development activities, growing awareness of drug safety, globalization of clinical trials, shift towards in silico modeling. The pharma admet testing market size is expected to see rapid growth in the next few years. It will grow to " $17.03 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to environmental toxicology and safety assessment, awareness of pharmacogenomics, focus on precision medicine, growth of biologics and biosimilars, integration of artificial intelligence (AI), expanded regulatory requirements, rise in orphan drug development. Major trends in the forecast period include increasing collaboration in research, rapid technological innovations, advancements in analytical technologies, continuous monitoring of drug safety, and environmental impact considerations. For further insights on this market, request a sample here

The pharma admet testingmarket covered in this report is segmented –
1) By Testing Type: In Vivo ADMET Testing; In Vitro ADMET Testing; In Silico ADMET Testing
2) By Technology: Cell Culture; High Throughput; Molecular Imaging; OMICS Technology
3) By Application: Systemic Toxicity; Renal Toxicity; Hepatotoxicity; Neurotoxicity; Other Applications Subsegments:
1) By In Vivo ADMET Testing: Animal Studies; Pharmacokinetics Studies; Toxicology Studies; Biodistribution Studies
2) By In Vitro ADMET Testing: Metabolism Studies; Drug-Drug Interaction Studies; Absorption Studies; Cytotoxicity and Safety Testing
3) By In Silico ADMET Testing: Predictive Modeling and Simulation; Quantitative Structure-Activity Relationship (QSAR) Analysis; Machine Learning Algorithms for ADMET Predictions; Software Tools for ADMET Profiling For further insights on this market, request a sample here

Asia-Pacific was the largest region in the pharma ADMET testing market in 2024. The regions covered in the pharma ADMET testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the pharma ADMET testing market include Thermo Fisher Scientific Inc., The Merck Group, Laboratory Corporation of America Holdings, IQVIA Inc., PPD ICON plc, Agilent Technologies Inc., Wuxi AppTec Co. Ltd., Catalent Inc., Covance Inc., Charles River Laboratories International Inc., Eurofins Scientific SE, Beckman Coulter Inc., Perkinelmer Inc., Albany Molecular Research Inc., Evotec A.G., CMIC Holdings Co. Ltd., Promega Corporation, Aptuit LLC, Symeres B.V., Biovia Corp., BioIVT LLC, Cyprotex Limited, InSphero AG, Admescope Ltd., Accelrys Inc. . For further insights on this market, request a sample here.

Major trends in this market include The Impact Of Product Innovations On The Pharma ADMET Testing Market. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Pharma ADMET Testing Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon